Abstract
Summary
Mobile cardiac telemetry (MCT) is a cardiac monitoring method that uses a small portable device to monitors a patient's cardiac activity. It records the patient's heartbeat as they run errands, exercise, and sleep.
The global market for ECG Mobile Cardiac Monitoring was estimated to be worth US$ 7690 million in 2023 and is forecast to a readjusted size of US$ 11110 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart's ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ECG Mobile Cardiac Monitoring, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of ECG Mobile Cardiac Monitoring by region & country, by Type, and by Application.
The ECG Mobile Cardiac Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ECG Mobile Cardiac Monitoring.
Market Segmentation
By Company
Baxter
SmartCardia
AliveCor
iRhythm Technologies Inc
MediBioSense Ltd
Philips
LifeLabs
Aerotel Medical Systems
HeartBug
Wellue
Bardy Diagnostics
Coala Life
ScottCare
Biotricity
Ranealth
Medtronic
Abbott
Boston Scientific Corporation
BIOTRONIK
Segment by Type:
Insertion Cardiac Monitor
Wearable Patch
Segment by Application
Medical
Household
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of ECG Mobile Cardiac Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of ECG Mobile Cardiac Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of ECG Mobile Cardiac Monitoring in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for ECG Mobile Cardiac Monitoring was estimated to be worth US$ 7690 million in 2023 and is forecast to a readjusted size of US$ 11110 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030
Abnormal heartbeats are called arrhythmias. It causes a decrease in the heart's ability to pump blood, which reduces blood supply to vital organs such as the brain. Without proper blood flow to the brain, it can cause a person to faint, and when the rhythm returns to normal, the person regains consciousness. Therefore, heart rhythm is associated with many diseases and requires treatment. It is important to look for the cause of the rhythm disturbance and monitor electrical activity. This can be monitored with the help of an implantable heart monitor, which has a battery life of up to three or four years. The ICM continuously monitors heart rhythm and automatically stores records for years in real-world scenarios. With the capability of long-term continuous monitoring, ICM has proven to be a sensitive method for detecting unexplained syncope, subclinical atrial fibrillation and palpitations. These devices automatically record heart rate without any external intervention. The ICM can capture information that is often missed by a Holter or standard electrocardiogram (ECG), but some heart rhythm abnormalities occur rarely. Existing studies of these devices have provided sufficient evidence that implantable heart monitors are suitable for patients with atrial fibrillation, syncope and even myocardial infarction.
Atrial fibrillation is an irregular and often rapid heart rate that increases the risk of stroke, heart failure and other heart-related complications. It is expected to affect 17.9 million people by 2050. Short-term monitoring is not optimal for understanding the burden. After radiofrequency ablation, the ICM has become the first choice for cardiac monitoring. Fainting is a disorder triggered by a sudden, temporary drop in blood flow to the brain, resulting in loss of consciousness and muscle control. This is due to decreased blood flow to the brain or any other organ in the body. Low blood pressure can also cause passing out. The International Study of Syncope of Unknown Etiology (ISSUE) highlights various aspects of the utility of ICMs in the transient loss of consciousness (TLOC) population. It has been observed that ICM is used more in syncope than conventional testing. Myocardial infarction, commonly known as a heart attack, is said to occur when blood flow to the heart is blocked or completely stopped. The use of ICMs in patients with acute myocardial infarction allows for continuous ECG monitoring and a more detailed understanding of the incidence of bradyarrhythmias and tachyarrhythmias than conventional follow-up.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ECG Mobile Cardiac Monitoring, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of ECG Mobile Cardiac Monitoring by region & country, by Type, and by Application.
The ECG Mobile Cardiac Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ECG Mobile Cardiac Monitoring.
Market Segmentation
By Company
Baxter
SmartCardia
AliveCor
iRhythm Technologies Inc
MediBioSense Ltd
Philips
LifeLabs
Aerotel Medical Systems
HeartBug
Wellue
Bardy Diagnostics
Coala Life
ScottCare
Biotricity
Ranealth
Medtronic
Abbott
Boston Scientific Corporation
BIOTRONIK
Segment by Type:
Insertion Cardiac Monitor
Wearable Patch
Segment by Application
Medical
Household
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of ECG Mobile Cardiac Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of ECG Mobile Cardiac Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of ECG Mobile Cardiac Monitoring in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 ECG Mobile Cardiac Monitoring Product Introduction
1.2 Global ECG Mobile Cardiac Monitoring Market Size Forecast
1.2.1 Global ECG Mobile Cardiac Monitoring Sales Value (2019-2030)
1.2.2 Global ECG Mobile Cardiac Monitoring Sales Volume (2019-2030)
1.2.3 Global ECG Mobile Cardiac Monitoring Sales Price (2019-2030)
1.3 ECG Mobile Cardiac Monitoring Market Trends & Drivers
1.3.1 ECG Mobile Cardiac Monitoring Industry Trends
1.3.2 ECG Mobile Cardiac Monitoring Market Drivers & Opportunity
1.3.3 ECG Mobile Cardiac Monitoring Market Challenges
1.3.4 ECG Mobile Cardiac Monitoring Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global ECG Mobile Cardiac Monitoring Players Revenue Ranking (2023)
2.2 Global ECG Mobile Cardiac Monitoring Revenue by Company (2019-2024)
2.3 Global ECG Mobile Cardiac Monitoring Players Sales Volume Ranking (2023)
2.4 Global ECG Mobile Cardiac Monitoring Sales Volume by Company Players (2019-2024)
2.5 Global ECG Mobile Cardiac Monitoring Average Price by Company (2019-2024)
2.6 Key Manufacturers ECG Mobile Cardiac Monitoring Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers ECG Mobile Cardiac Monitoring Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of ECG Mobile Cardiac Monitoring
2.9 ECG Mobile Cardiac Monitoring Market Competitive Analysis
2.9.1 ECG Mobile Cardiac Monitoring Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by ECG Mobile Cardiac Monitoring Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ECG Mobile Cardiac Monitoring as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Insertion Cardiac Monitor
3.1.2 Wearable Patch
3.2 Global ECG Mobile Cardiac Monitoring Sales Value by Type
3.2.1 Global ECG Mobile Cardiac Monitoring Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global ECG Mobile Cardiac Monitoring Sales Value, by Type (2019-2030)
3.2.3 Global ECG Mobile Cardiac Monitoring Sales Value, by Type (%) (2019-2030)
3.3 Global ECG Mobile Cardiac Monitoring Sales Volume by Type
3.3.1 Global ECG Mobile Cardiac Monitoring Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global ECG Mobile Cardiac Monitoring Sales Volume, by Type (2019-2030)
3.3.3 Global ECG Mobile Cardiac Monitoring Sales Volume, by Type (%) (2019-2030)
3.4 Global ECG Mobile Cardiac Monitoring Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medical
4.1.2 Household
4.2 Global ECG Mobile Cardiac Monitoring Sales Value by Application
4.2.1 Global ECG Mobile Cardiac Monitoring Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global ECG Mobile Cardiac Monitoring Sales Value, by Application (2019-2030)
4.2.3 Global ECG Mobile Cardiac Monitoring Sales Value, by Application (%) (2019-2030)
4.3 Global ECG Mobile Cardiac Monitoring Sales Volume by Application
4.3.1 Global ECG Mobile Cardiac Monitoring Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global ECG Mobile Cardiac Monitoring Sales Volume, by Application (2019-2030)
4.3.3 Global ECG Mobile Cardiac Monitoring Sales Volume, by Application (%) (2019-2030)
4.4 Global ECG Mobile Cardiac Monitoring Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global ECG Mobile Cardiac Monitoring Sales Value by Region
5.1.1 Global ECG Mobile Cardiac Monitoring Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global ECG Mobile Cardiac Monitoring Sales Value by Region (2019-2024)
5.1.3 Global ECG Mobile Cardiac Monitoring Sales Value by Region (2025-2030)
5.1.4 Global ECG Mobile Cardiac Monitoring Sales Value by Region (%), (2019-2030)
5.2 Global ECG Mobile Cardiac Monitoring Sales Volume by Region
5.2.1 Global ECG Mobile Cardiac Monitoring Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global ECG Mobile Cardiac Monitoring Sales Volume by Region (2019-2024)
5.2.3 Global ECG Mobile Cardiac Monitoring Sales Volume by Region (2025-2030)
5.2.4 Global ECG Mobile Cardiac Monitoring Sales Volume by Region (%), (2019-2030)
5.3 Global ECG Mobile Cardiac Monitoring Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
5.4.2 North America ECG Mobile Cardiac Monitoring Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
5.5.2 Europe ECG Mobile Cardiac Monitoring Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
5.6.2 Asia Pacific ECG Mobile Cardiac Monitoring Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
5.7.2 South America ECG Mobile Cardiac Monitoring Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
5.8.2 Middle East & Africa ECG Mobile Cardiac Monitoring Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions ECG Mobile Cardiac Monitoring Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions ECG Mobile Cardiac Monitoring Sales Value
6.2.1 Key Countries/Regions ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.2.2 Key Countries/Regions ECG Mobile Cardiac Monitoring Sales Volume, 2019-2030
6.3 United States
6.3.1 United States ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.3.2 United States ECG Mobile Cardiac Monitoring Sales Value by Type (%), 2023 VS 2030
6.3.3 United States ECG Mobile Cardiac Monitoring Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.4.2 Europe ECG Mobile Cardiac Monitoring Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe ECG Mobile Cardiac Monitoring Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.5.2 China ECG Mobile Cardiac Monitoring Sales Value by Type (%), 2023 VS 2030
6.5.3 China ECG Mobile Cardiac Monitoring Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.6.2 Japan ECG Mobile Cardiac Monitoring Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan ECG Mobile Cardiac Monitoring Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.7.2 South Korea ECG Mobile Cardiac Monitoring Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea ECG Mobile Cardiac Monitoring Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.8.2 Southeast Asia ECG Mobile Cardiac Monitoring Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia ECG Mobile Cardiac Monitoring Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India ECG Mobile Cardiac Monitoring Sales Value, 2019-2030
6.9.2 India ECG Mobile Cardiac Monitoring Sales Value by Type (%), 2023 VS 2030
6.9.3 India ECG Mobile Cardiac Monitoring Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Company Information
7.1.2 Baxter Introduction and Business Overview
7.1.3 Baxter ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Baxter ECG Mobile Cardiac Monitoring Product Offerings
7.1.5 Baxter Recent Development
7.2 SmartCardia
7.2.1 SmartCardia Company Information
7.2.2 SmartCardia Introduction and Business Overview
7.2.3 SmartCardia ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.2.4 SmartCardia ECG Mobile Cardiac Monitoring Product Offerings
7.2.5 SmartCardia Recent Development
7.3 AliveCor
7.3.1 AliveCor Company Information
7.3.2 AliveCor Introduction and Business Overview
7.3.3 AliveCor ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.3.4 AliveCor ECG Mobile Cardiac Monitoring Product Offerings
7.3.5 AliveCor Recent Development
7.4 iRhythm Technologies Inc
7.4.1 iRhythm Technologies Inc Company Information
7.4.2 iRhythm Technologies Inc Introduction and Business Overview
7.4.3 iRhythm Technologies Inc ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.4.4 iRhythm Technologies Inc ECG Mobile Cardiac Monitoring Product Offerings
7.4.5 iRhythm Technologies Inc Recent Development
7.5 MediBioSense Ltd
7.5.1 MediBioSense Ltd Company Information
7.5.2 MediBioSense Ltd Introduction and Business Overview
7.5.3 MediBioSense Ltd ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.5.4 MediBioSense Ltd ECG Mobile Cardiac Monitoring Product Offerings
7.5.5 MediBioSense Ltd Recent Development
7.6 Philips
7.6.1 Philips Company Information
7.6.2 Philips Introduction and Business Overview
7.6.3 Philips ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Philips ECG Mobile Cardiac Monitoring Product Offerings
7.6.5 Philips Recent Development
7.7 LifeLabs
7.7.1 LifeLabs Company Information
7.7.2 LifeLabs Introduction and Business Overview
7.7.3 LifeLabs ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.7.4 LifeLabs ECG Mobile Cardiac Monitoring Product Offerings
7.7.5 LifeLabs Recent Development
7.8 Aerotel Medical Systems
7.8.1 Aerotel Medical Systems Company Information
7.8.2 Aerotel Medical Systems Introduction and Business Overview
7.8.3 Aerotel Medical Systems ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Aerotel Medical Systems ECG Mobile Cardiac Monitoring Product Offerings
7.8.5 Aerotel Medical Systems Recent Development
7.9 HeartBug
7.9.1 HeartBug Company Information
7.9.2 HeartBug Introduction and Business Overview
7.9.3 HeartBug ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.9.4 HeartBug ECG Mobile Cardiac Monitoring Product Offerings
7.9.5 HeartBug Recent Development
7.10 Wellue
7.10.1 Wellue Company Information
7.10.2 Wellue Introduction and Business Overview
7.10.3 Wellue ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Wellue ECG Mobile Cardiac Monitoring Product Offerings
7.10.5 Wellue Recent Development
7.11 Bardy Diagnostics
7.11.1 Bardy Diagnostics Company Information
7.11.2 Bardy Diagnostics Introduction and Business Overview
7.11.3 Bardy Diagnostics ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Bardy Diagnostics ECG Mobile Cardiac Monitoring Product Offerings
7.11.5 Bardy Diagnostics Recent Development
7.12 Coala Life
7.12.1 Coala Life Company Information
7.12.2 Coala Life Introduction and Business Overview
7.12.3 Coala Life ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Coala Life ECG Mobile Cardiac Monitoring Product Offerings
7.12.5 Coala Life Recent Development
7.13 ScottCare
7.13.1 ScottCare Company Information
7.13.2 ScottCare Introduction and Business Overview
7.13.3 ScottCare ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.13.4 ScottCare ECG Mobile Cardiac Monitoring Product Offerings
7.13.5 ScottCare Recent Development
7.14 Biotricity
7.14.1 Biotricity Company Information
7.14.2 Biotricity Introduction and Business Overview
7.14.3 Biotricity ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Biotricity ECG Mobile Cardiac Monitoring Product Offerings
7.14.5 Biotricity Recent Development
7.15 Ranealth
7.15.1 Ranealth Company Information
7.15.2 Ranealth Introduction and Business Overview
7.15.3 Ranealth ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Ranealth ECG Mobile Cardiac Monitoring Product Offerings
7.15.5 Ranealth Recent Development
7.16 Medtronic
7.16.1 Medtronic Company Information
7.16.2 Medtronic Introduction and Business Overview
7.16.3 Medtronic ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Medtronic ECG Mobile Cardiac Monitoring Product Offerings
7.16.5 Medtronic Recent Development
7.17 Abbott
7.17.1 Abbott Company Information
7.17.2 Abbott Introduction and Business Overview
7.17.3 Abbott ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Abbott ECG Mobile Cardiac Monitoring Product Offerings
7.17.5 Abbott Recent Development
7.18 Boston Scientific Corporation
7.18.1 Boston Scientific Corporation Company Information
7.18.2 Boston Scientific Corporation Introduction and Business Overview
7.18.3 Boston Scientific Corporation ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Boston Scientific Corporation ECG Mobile Cardiac Monitoring Product Offerings
7.18.5 Boston Scientific Corporation Recent Development
7.19 BIOTRONIK
7.19.1 BIOTRONIK Company Information
7.19.2 BIOTRONIK Introduction and Business Overview
7.19.3 BIOTRONIK ECG Mobile Cardiac Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.19.4 BIOTRONIK ECG Mobile Cardiac Monitoring Product Offerings
7.19.5 BIOTRONIK Recent Development
8 Industry Chain Analysis
8.1 ECG Mobile Cardiac Monitoring Industrial Chain
8.2 ECG Mobile Cardiac Monitoring Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 ECG Mobile Cardiac Monitoring Sales Model
8.5.2 Sales Channel
8.5.3 ECG Mobile Cardiac Monitoring Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer